
Srujan Pharmaceuticals Private Limited
Pharmaceutical company specializing in manufacturing, trading, and research of healthcare products.
Pharmaceutical company specializing in manufacturing, trading, and research of healthcare products.
Aurangabad, Maharashtra, India
+91-XXXXXXXXXX
U24290MH2022PTC385915
385915
Private Limited Indian Non-Government Company
01 Jul 2022
-
-
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vishal Kulkarni ![]() | Director | 01-Jul-2022 | Current |
Akshay Dalal ![]() | Director | 01-Jul-2022 | Current |
Enhance accessibility to Srujan Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Srujan Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Akshay Dalal is a mutual person
There are no open charges registered against the company as per our records.
Srujan Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Srujan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srujan Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Vishal Ramdas Kulkarni was appointed as a Director was appointed as a Director on 01 Jul 2022 & has been associated with this company since 2 years 10 months .
Akshay Anilrao Dalal was appointed as a Director was appointed as a Director on 01 Jul 2022 & has been associated with this company since 2 years 10 months .
Srujan Pharmaceuticals Private Limited was registered on 01 Jul 2022 with Roc Mumbai & aged 2 years 10 months as per MCA records.
Srujan Pharmaceuticals Private Limited was incorporated on 01 Jul 2022.
The authorized share capital of Srujan Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Srujan Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Srujan Pharmaceuticals Private Limited is Smt Kulkarni Chanchala Ramdas, Mitravihar Colony Plot No 5 Garkheda, Aurangabad, Maharashtra, India, 431001.
The corporate identification number (CIN) of Srujan Pharmaceuticals Private Limited is U24290MH2022PTC385915 and the company number is 385915 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.